Telavancin in Experimental Murine Pneumococcal Pneumonia

Journal of Immune Based Therapies, Vaccines and Antimicrobials

ISSN Print: 2168-1546
ISSN Online: 2168-1554
www.scirp.net/journal/jibtva
E-mail: [email protected]

Citations

"Telavancin in Experimental Murine Pneumococcal Pneumonia"
written by Suzannah M. Schmidt, Melissa J. Karau, Jayawant N. Mandrekar, James M. Steckelberg, Robin Patel,
published by Journal of Immune Based Therapies, Vaccines and Antimicrobials, Vol.1 No.2, 2012

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens
	Therapeutic Advances in Infectious Disease, 2017

[2]	Activity of electrical current in experimental Propionibacterium acnes foreign-body osteomyelitis
	2017

[3]	Activity of Electrical Current in Experimental Propionibacterium acnes Foreign Body Osteomyelitis
	2016

[4]	A strain-independent method to induce progressive and lethal pneumococcal pneumonia in neutropenic mice
	Journal of biomedical science, 2015

[1]	Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens Therapeutic Advances in Infectious Disease, 2017 DOI:10.1177/2049936117690501

[2]	Activity of Electrical Current in Experimental Propionibacterium acnes Foreign-Body Osteomyelitis Antimicrobial Agents and Chemotherapy, 2017 DOI:10.1128/AAC.01863-16

[3]	A strain-independent method to induce progressive and lethal pneumococcal pneumonia in neutropenic mice Journal of Biomedical Science, 2015 DOI:10.1186/s12929-015-0124-4

	[email protected]
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Immune Based Therapies, Vaccines and Antimicrobials

Journal of Immune Based Therapies, Vaccines and Antimicrobials

Journals Menu

Guidelines & Policies

Home

About SCIRP

Service

Policies